Short Interest in Anbio Biotechnology (NASDAQ:NNNN) Expands By 50.5%

Anbio Biotechnology (NASDAQ:NNNN) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 47,525 shares, an increase of 50.5% from the July 15th total of 31,583 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 38,778 shares, the days-to-cover ratio is presently 1.2 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Anbio Biotechnology Price Performance

Shares of NASDAQ:NNNN opened at $7.75 on Thursday. The firm has a 50 day moving average of $11.73 and a 200 day moving average of $20.84. Anbio Biotechnology has a 52 week low of $7.08 and a 52 week high of $54.50.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.